Colin Calvert

Chief Financial Officer, Nicoya Lifesciences Inc

Colin has spent his career working or advising hundreds of high-growth, emerging technology businesses. Currently, he is accountable for financial strategy and human resources as CFO at Nicoya Lifesciences, a business that is improving human life by helping scientists succeed with the power of benchtop digital proteomic tools. Nicoya Lifesciences has over 100 employees and uses nanotechnology, microfluidics, and AI to create products that enable scientists to better understand complex areas within the field of proteomics. Colin has led or co-led over $45M in dilutive financing including priced equity, convertible notes and SAFEs and the placement of over $10M in initial debt/credit or debt/credit refinancing capital. Colin has also led or co-led over $10M in grant funding including multiple >$1M SR&ED claims and multiple >$2M awards across various government funding agencies. Colin mentored at Velocity out of the University of Waterloo for over 5 years and now mentors at Volta since moving to Halifax in late 2022. Prior to his role at Nicoya, Colin founded and operated SolveCFO, a fractional CFO company focused exclusively on developing financial strategy and growth supporting infrastructure at startups which he sold to a partner he had added a few years after founding the business. Colin’s breadth of advisory spans from financing across various forms of capital, developing efficient/effective financial infrastructure, shareholder/stakeholder management (including cap table, SHAG and other governance documents), financial/sales projection modelling, data room building, domestic and cross border tax, HRIS and compensation planning, audit planning and other critical areas within finance & HR.